Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 171
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05908084 | To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis | ||
| NCT04980638 | Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia | ||
| NCT03622658 | Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis | ||
| NCT03447314 | Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors | ||
| NCT06412250 | A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) | ||
| NCT04333147 | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) | ||
| NCT03077477 | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT04540393 | AZD1222 Vaccine for the Prevention of COVID-19 | ||
| NCT05856266 | An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa | ||
| NCT03369262 | PoC Study of OBE022 in Threatened Preterm Labour | ||
| NCT05925595 | Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis | ||
| NCT05186324 | Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion | ||
| NCT04168814 | Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study | ||
| NCT05310734 | PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies | ||
| NCT05030831 | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE | ||
| NCT03553108 | A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. | ||
| NCT07049653 | Anifrolumab Pregnancy Study | ||
| NCT05632211 | A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants | ||
| NCT07405983 | TOUCH® CMC 1 New Enrollment US Study | ||
| NCT05169307 | CPX-351 Real-World Effectiveness and Safety Study | ||
| NCT05761444 | Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients | ||
| NCT05264506 | Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | ||
| NCT03606603 | Nutrition Insights Day Asia | ||
| NCT02503033 | A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies | ||
| NCT06504446 | Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough | ||
| NCT05267613 | Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. | ||
| NCT04151342 | CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) | ||
| NCT03254446 | Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension | ||
| NCT04246762 | Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4 | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer | ||
| NCT02654470 | Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only) | ||
| NCT03285672 | FP-101 for the Treatment of Hot Flashes in Postmenopausal Women | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT03566082 | Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe | ||
| NCT03193476 | Registry for Patients With X-Linked Hypophosphatemia | ||
| NCT03956355 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) | ||
| NCT04840849 | Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults | ||
| NCT05189977 | A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline | ||
| NCT04699812 | Atrial Fibrillation Algorithms Clinical Validation Study | ||
| NCT04620148 | TAK-242 in Patients With Acute Alcoholic Hepatitis | ||
| NCT05918978 | Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS | ||
| NCT05776472 | A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | ||
| NCT04641481 | An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers | ||
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy | ||
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | ||
| NCT05817669 | A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) | ||
| NCT06042049 | A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab | ||
| NCT05663515 | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs |
